Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Institute Of Medicinal Biotechnology Cams & Pumc has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, SULLIVAN, DENNIS JOHN, who is the busiest examiner for the portfolio. The prosecution is confined to a distinct art unit, representing the focus for the institute's current patenting efforts. SULLIVAN, DENNIS JOHN is responsible for the active prosecution workload.
The presence of a distinct art unit and examiner for the pending office action suggests a centralized prosecution path. Practitioners should prepare for a consistent examination process, as the current data shows no diversification across different examiners or art units within the Biotechnology & Pharmaceuticals sector. Because the pending office action is the only matter currently being handled, the institute's success in this technology area depends on the interaction with this examiner. This relationship between actions, examiners, and art units minimizes administrative complexity but increases reliance on an individual.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SULLIVAN, DENNIS JOHN | 1 | 57.3% | +49.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18713459 | miR-25802 CLUSTER AS BIOMARKER FOR INFLAMMATION-ASSOCIATED DISEASE, AND USE OF miR-25802 CLUSTER | SULLIVAN, DENNIS JOHN | — |
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18713459 | miR-25802 CLUSTER AS BIOMARKER FOR INFLAMMATION-ASSOCIATED DISEASE, AND USE OF miR-25802 CLUSTER | SULLIVAN, DENNIS JOHN | 1642 | §112 | Non-Final OA | — | Pending | May 31, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial